I talked to PTX ...The last update was 15 September and it was stated that the the AML trial was imminent.I was told that we are currently going through the screening process and it was very detailed...very important to have the right patients to give the trial every chance of success...this procedure does lead to delays.
It will be announced to the market when the first patient is dosed.
PTX Price at posting:
9.6¢ Sentiment: Buy Disclosure: Held
